Skip to main content

Year: 2020

Kratos Awarded Contract Modification Valued at $22 Million to Provide Satellite Command and Control System Sustainment

SAN DIEGO, Dec. 29, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has received a delivery order valued at $22 million and funded at $11.8 million for satellite and communication system products, hardware and equipment. This modification is against a previously-awarded contract.This award is for mission activity and maneuver planning, telemetry processing, commanding, orbit and attitude management, resource management, space vehicle and ground system simulation, security, support planning and execution, training and testing. The modification will now sustain new capability such as virtualization, additional satellite constellation capacity and cybersecurity enhancements. Satellite state-of-health operations include launch,...

Continue reading

Par Pacific Holdings Management to Participate in Virtual Investor Conferences

HOUSTON, Dec. 29, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that members of its management team will present at the 3rd Annual Mizuho Virtual Refining Conference on January 5, 2021 at 1:00 pm CT. They will also participate in a panel discussion at the Goldman Sachs Global Energy Conference 2021 on January 7, 2021 at 9:30 am CT and host 1×1 sessions with investors throughout the day. The most current investor presentation is available on the investor relations section of Par Pacific’s website at www.parpacific.com.About Par PacificPar Pacific Holdings, Inc. (NYSE: PARR), headquartered in Houston, Texas, owns and operates market-leading energy, infrastructure, and retail businesses. Par Pacific’s strategy is to acquire and develop businesses in logistically complex markets. Par...

Continue reading

Intra-Cellular Therapies Announces the Initiation of Clinical Trials for ITI-LLAI, a Long-Acting Injectable Formulation of Lumateperone for the Treatment of Schizophrenia and for ITI-333, a Novel Treatment for Opioid Use Disorder

The Company continues expansion of its lumateperone programs with the advancement of a Long-Acting injectable formulation into clinical trials.ITI-333 introduces a unique pharmacology for the treatment of opioid use disorder.NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the initiation of clinical programs for the Company’s lumateperone long-acting injectable formulation (ITI-LLAI) and for ITI-333, a novel molecule for the treatment of opioid use disorder.“I am pleased to announce that two important proprietary programs have advanced into human clinical testing, further demonstrating our commitment to patients through the development of...

Continue reading

Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year

TEMPLE CITY, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics (Nasdaq: FLGT), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Company has extended its partnership with the New York City Department of Education (or “NYC DOE”) and NYC Health + Hospitals for COVID-19 testing through the remainder of the 2021 school year. The contract was awarded after a competitive process where Fulgent demonstrated its COVID-19 testing capabilities, including its accurate and reliable test offerings, easy to use reporting systems and fast turnaround times.Through the agreement, Fulgent will provide COVID-19 testing for thousands of students and employees at many K-12 schools in New York City on a daily basis.  The NYC DOE will leverage Fulgent’s FDA EUA-approved...

Continue reading

BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021

NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) — BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that CEO Dr. Lan Huang is scheduled to present virtually at the 39th Annual J.P. Morgan Healthcare Conference (JPM) on Thursday, January 14, 2021 at 7:30 a.m. ET, and will be available for 1×1 meetings. The BeyondSpring leadership team also will be available for one-on-one meetings during the LifeSci Advisors Corporate Access Event on January 7-8 and 11-13, 2021.Details for both events are as follows:39th Annual J.P. Morgan Healthcare Conference (Corporate Presentation)2021 LifeSci Advisors Corporate Access EventA video replay of the JPM presentation will be available on the Events and Presentations section investor...

Continue reading

POET Technologies to Present at the Needham Growth Conference on January 14

TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, announced today that Vivek Rajgarhia, President and General Manager, and Thomas Mika, Executive Vice President & Chief Financial Officer, will participate at the Needham Growth Conference, which will be held as a virtual event. Management is scheduled to present at 4:15 p.m. ET on Thursday, January 14, 2021 and will be available throughout the day to meet with investors attending the conference.Portfolio managers and analysts who would like to request a meeting with management should email conferences@needhamco.com or contact their Needham representative....

Continue reading

Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference

MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.The TRHC presentation is scheduled for Thursday, January 14, 2021 at 4:30 p.m. EST. An audio replay of the presentation will be available at https://ir.tabularasahealthcare.com/.About Tabula Rasa HealthCareTabula Rasa HealthCare (TRHC) provides patient medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk,...

Continue reading

Eagle Bulk Shipping Inc. Acquires Two Modern Ultramax Bulkcarriers

STAMFORD, Conn., Dec. 29, 2020 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk”, “Eagle” or the “Company”), one of the world’s largest owner-operators within the Supramax / Ultramax drybulk segment, today announced that it has purchased two modern high-specification SDARI-64 scrubber-fitted Ultramax bulkcarriers. This follows the Company’s recently-announced acquisition of a similar specification vessel.The first vessel, which was built in 2015 and will be renamed the M/V Helsinki Eagle, has been acquired for USD 16.5 million. The second vessel, which was built in 2016 and will be renamed the M/V Stockholm Eagle, has been acquired for USD 17.65 million.Both ships were constructed at Chengxi Shipyard Co. Ltd. Closings are expected during the first quarter of 2021, with the M/V Stockholm Eagle delivering to...

Continue reading

Nevada Copper Completes Key Underground Milestone

YERINGTON, Nev., Dec. 29, 2020 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (OTC:NEVDF) (“Nevada Copper” or the “Company’’) is pleased to announce the completion of the underground materials handling system of the main shaft. The materials handling system represents a significant milestone in the construction of the Company’s underground project which included sinking the vent shaft, sinking the main shaft, and construction of the processing plant. The completion of this milestone allows for a significant increase in hoisting rates, from currently 1000 tpd to ultimately 5000 tpd once commissioning and ramp-up are completed. This is expected to enable the underground mine to deliver substantially higher volumes of ore directly from the mine to the processing plant.Mike Ciricillo CEO of Nevada Copper comments, “I am very pleased...

Continue reading

NexTech To Buy $2million in Bitcoin with Treasury

VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leading provider of virtual and augmented reality (AR) experience technologies and services for eCommerce, education, conferences and events today announced that it plans to make an initial investment of $2million in Bitcoin and may add more in 2021.NexTech CEO, Evan Gappelberg comments, “Our investment in Bitcoin is part of our new capital diversification and allocation strategy with the intent to maximize long-term value for our shareholders.” He continues, “This initial investment reflects our belief that Bitcoin is a long-term store of value and an attractive investment asset with more long-term appreciation potential than holding cash, which is currently yielding 0.06%. Bitcoin is a digital version...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.